APA (7th ed.) Citation

Hu, Y., Xu, X., Liu, X., He, C., Ouyang, Y., Li, N., . . . Lu, N. (2023). Fourteen-day vonoprazan and low- or high-dose amoxicillin dual therapy for eradicating Helicobacter pylori infection: A prospective, open-labeled, randomized non-inferiority clinical study. Frontiers in immunology, 13, 1049908. https://doi.org/10.3389/fimmu.2022.1049908

Chicago Style (17th ed.) Citation

Hu, Yi, et al. "Fourteen-day Vonoprazan and Low- or High-dose Amoxicillin Dual Therapy for Eradicating Helicobacter Pylori Infection: A Prospective, Open-labeled, Randomized Non-inferiority Clinical Study." Frontiers in Immunology 13 (2023): 1049908. https://doi.org/10.3389/fimmu.2022.1049908.

MLA (9th ed.) Citation

Hu, Yi, et al. "Fourteen-day Vonoprazan and Low- or High-dose Amoxicillin Dual Therapy for Eradicating Helicobacter Pylori Infection: A Prospective, Open-labeled, Randomized Non-inferiority Clinical Study." Frontiers in Immunology, vol. 13, 2023, p. 1049908, https://doi.org/10.3389/fimmu.2022.1049908.